Assessment of the feed additives l‐carnitine (3a910) and l‐carnitine l‐tartrate (3a911) for all animal species for the renewal of their authorisation (Lonza Sales AG)

Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion (safety and efficacy) on the application for the renewal of the authorisation of l‐carnitine (3a910) and l‐carnitine l‐tartrate (3a911) as nutritional feed additives. The additives are currently...

Full description

Bibliographic Details
Published in:EFSA Journal
Main Authors: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Roberto Edoardo Villa, Giovanna Azimonti, Eleftherios Bonos, Henrik Christensen, Mojca Durjava, Birgit Dusemund, Ronette Gehring, Boet Glandorf, Maryline Kouba, Marta López‐Alonso, Francesca Marcon, Carlo Nebbia, Alena Pechová, Miguel Prieto‐Maradona, Ilen Röhe, Katerina Theodoridou, Montserrat Anguita, Matteo L. Innocenti, Joana P. Firmino
Format: Article
Language:English
Published: Wiley 2025-10-01
Subjects:
Online Access:https://doi.org/10.2903/j.efsa.2025.9690
Description
Summary:Abstract Following a request from the European Commission, EFSA was asked to deliver a scientific opinion (safety and efficacy) on the application for the renewal of the authorisation of l‐carnitine (3a910) and l‐carnitine l‐tartrate (3a911) as nutritional feed additives. The additives are currently authorised for use in all animal species. The applicant has provided evidence that the additives currently in the market comply with the existing conditions of authorisation. Two examples of l‐carnitine preparations currently placed on the market are described in the application. There is no new evidence that would lead the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) to reconsider its previous conclusions. Thus, the FEEDAP Panel concluded that the additives remain safe for the target species, consumers and the environment. Regarding user safety, the additives are not irritants to skin and eyes nor skin sensitisers. In the absence of data on the different preparations, the FEEDAP Panel could not conclude on the safety for the user of any preparations containing l‐carnitine. There is no need to assess the efficacy of the additives in the context of the renewal of the authorisation.
ISSN:1831-4732